CompuGroup Medical SE & Co. KGaA
CMPVF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $351,303 | $286,156 | $308,690 | $283,444 |
| % Growth | 22.8% | -7.3% | 8.9% | – |
| Cost of Goods Sold | $258,416 | $44,381 | $54,307 | $45,293 |
| Gross Profit | $82,735 | $241,775 | $254,383 | $238,151 |
| % Margin | 23.6% | 84.5% | 82.4% | 84% |
| R&D Expenses | $5,630 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,359 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $52,888 | $219,457 | $219,674 | $238,151 |
| Operating Expenses | $60,877 | $219,457 | $219,674 | $238,151 |
| Operating Income | $106,362 | $22,318 | $34,709 | $0 |
| % Margin | 30.3% | 7.8% | 11.2% | 0% |
| Other Income/Exp. Net | -$97,310 | -$6,538 | -$31,097 | $12,273 |
| Pre-Tax Income | $9,052 | $15,780 | $3,612 | $12,273 |
| Tax Expense | $2,801 | $4,732 | $9,649 | $3,682 |
| Net Income | $6,104 | $10,917 | -$6,470 | $8,621 |
| % Margin | 1.7% | 3.8% | -2.1% | 3% |
| EPS | 0.12 | 0.211 | -0.13 | 0.17 |
| % Growth | -43.1% | 262.3% | -176.5% | – |
| EPS Diluted | 0.12 | 0.211 | -0.13 | 0.17 |
| Weighted Avg Shares Out | 51,820 | 51,714 | 51,714 | 51,714 |
| Weighted Avg Shares Out Dil | 51,978 | 51,714 | 51,714 | 51,714 |
| Supplemental Information | – | – | – | – |
| Interest Income | $482 | $3,347 | $78 | $0 |
| Interest Expense | $8,597 | $8,606 | $2,714 | $14,479 |
| Depreciation & Amortization | $31,625 | $27,156 | $29,351 | $27,333 |
| EBITDA | $53,426 | $51,542 | $35,677 | $54,085 |
| % Margin | 15.2% | 18% | 11.6% | 19.1% |